Eagle Pharmaceuticals Inc Stock
Eagle Pharmaceuticals Inc gained 1.810% today.
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Eagle Pharmaceuticals Inc | 1.810% | 15.625% | -7.500% | -76.995% | -0.893% | -87.386% | -91.589% |
Rockwell Medical Inc. | -0.480% | -6.980% | -0.543% | -41.594% | -15.456% | -81.605% | -97.107% |
Avid Bioservices Inc | -1.900% | 1.307% | 20.155% | -53.030% | 27.049% | -52.160% | 137.839% |
Gritstone Oncology Inc | -17.770% | -18.396% | -16.952% | -69.813% | -60.845% | -90.515% | - |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat